Markets.com Logo

CORFX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    20.1618$
  • Previous Close
    20.1618$
  • 52 Week Change
    1.25$
  • Day Range
    0.00$
  • 52 Week High/Low
    18.8343$ - 20.08$
  • Dividend Per Share
    --
  • Market cap
    0$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

CORFX.US represents the stock of Corinthian Capital Fund I LP. It is a closed-end investment fund trading on the US OTC (Over-the-Counter) market. Corinthian Capital Fund I LP focuses on making private equity investments in smaller middle-market companies primarily located in the United States. These investments are generally made in companies undergoing change in ownership and control, strategic repositioning, or operational improvement. The fund aims to generate long-term capital appreciation through these private equity investments. As a closed-end fund, its shares trade on the secondary market like any other stock, and its price may not always reflect its net asset value.
US index analysis: Dow Jones Industrial Average dropped over 768 points, why is Dow falling?

US index analysis: Dow Jones Industrial Average dropped over 768 points, why is Dow falling?

Frances Wang|--

The Hormuz Dilemma: Allies Face a Thorny Choice Over Oil Security and International Law

Noah Lee|--

Iran Conflict Fuels Oil Surge, Threatening US Growth and Inflation, Delaying Fed Rate Cuts

Liam James|--

Federal Reserve Holds Rates Steady, Dot Plot Signals Gradual Future Cuts Amid Economic Uncertainty

Emma Rose|--
Social media stock analysis: Why Meta Platforms (META) stock is falling today?

Social media stock analysis: Why Meta Platforms (META) stock is falling today?

Ghko B|--

Who Controls the Strait of Hormuz: The Decisive Battle in the US-Iran Conflict

Ava Grace|--

Meta's Latest Layoffs: Signal of Redundancy or AI Investment Returns?

Noah Lee|--

Factors

Company Performance: Corvus Pharmaceuticals' clinical trial results for its drug candidates significantly impact the stock price. Positive data boosts confidence, while negative results can lead to declines. Market Sentiment: Overall investor confidence and risk appetite influence CORFX.US. A bullish market tends to lift most stocks, while a bearish market often pressures prices downward. Regulatory Approvals: FDA decisions regarding Corvus' drugs are critical. Approval can drive the stock higher, whereas rejection or delays can negatively affect it. Competition: The competitive landscape within the biotechnology industry affects Corvus. The success of competing drugs or therapies can impact investor perception. Financial Health: Corvus' cash reserves, burn rate, and ability to secure funding are essential. Strong financial stability inspires confidence, while concerns about funding can weigh on the stock. Economic Conditions: Broad economic factors, such as interest rates, inflation, and recessionary fears, can affect investor sentiment toward biotech companies.

People Also Watch

Latest news

ASX 200 Index today: ASX 200 (AXJO) shows resilience amid global uncertainty

ASX 200 Index today: ASX 200 (AXJO) shows resilience amid global uncertainty

Ghko B|--
Gold price today, March 20: Gold price is crashing, XAU/USD saw below $4,700

Gold price today, March 20: Gold price is crashing, XAU/USD saw below $4,700

Ghko B|--

US Strategic Petroleum Reserve Release: Market Impact and Trader Strategies

Sophia Claire|--

Latest Education Articles

Commodity CFDs explained: How to trade the price of gold (XAU) CFDs online in UAE?

Commodity CFDs explained: How to trade the price of gold (XAU) CFDs online in UAE?

Ghko B|--
Commodity Market Terms: What Are Basic Commdity Market Terms for Beginners in UAE?

Commodity Market Terms: What Are Basic Commdity Market Terms for Beginners in UAE?

Ghko B|--
How to trade top 3 cryptos in UAE: Bitcoin (BTC/USD), Ethereum (ETH/USD), Ripple (XRP/USD)?

How to trade top 3 cryptos in UAE: Bitcoin (BTC/USD), Ethereum (ETH/USD), Ripple (XRP/USD)?

Ghko B|--